Back to comparisons

Comparison

Creatine vs Dihydromyricetin (DHM)

FieldCreatineDihydromyricetin (DHM)
Categoryamino-acidamino-acid
Dose range3000–5000mg300–600mg
Half-life3h
Onset
EvidenceEVIDENCEAEVIDENCEB
Safety●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs1800380

The comparison in plain English

Auto-generated from data

Creatine and Dihydromyricetin (DHM) are both in the amino-acid category respectively. Creatine The most-studied performance supplement in history, now well-evidenced as a cognitive enhancer in its own right. Dihydromyricetin (DHM) Flavonoid from Hovenia dulcis (Japanese raisin tree).

Bottom line

Creatine (evidence A, safety 5/5) has a weaker evidence base than Dihydromyricetin (DHM) (evidence B, safety 4/5). Creatine has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Creatine if

Creatine is the better fit when your goal aligns with its mechanism (Phosphorylated by creatine kinase to phosphocreatine, the fastest available ATP buffer in the cell (millisecond timescale)) and the dose range (3000–5000mg) suits your protocol. Half-life is 3h.

Choose Dihydromyricetin (DHM) if

Dihydromyricetin (DHM) is the better fit when your goal aligns with its mechanism (Positive allosteric modulator of GABA-A receptors at the benzodiazepine binding site) and the dose range (300–600mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →